Is a complete LRMR research report available?

No complete published report is available for Larimar Therapeutics, Inc. (LRMR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Larimar Therapeutics, Inc. (LRMR)

NASDAQ: LRMR · USD

$3.83

+0.19 (+5.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LRMR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	399.3M
Net income (ttm)	-166M
EPS (ttm)	-$2.09
Shares out	104.4M
Volume	1,033,069
Beta	0.84
Price target	$14.4	+276.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -166M
EPS (ttm): -$2.09
Market cap: 399.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All LRMR indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001374690
Company name	Larimar Therapeutics, Inc.
Country	United States
Country code	US
Cusip	517125100
Employees	71
Employees Change	6%
Employees Change Percent	9.23
Enterprise value	$202.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US5171251003
Last refreshed	2026-07-31
Market cap	$399.3M
Market cap category	Small-Cap
Price	$3.83
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	LRMR
Website	https://www.larimartx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-41.58%
FCF yield	-32.89%
P/B ratio	2.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-166M
Net Income Growth Years	0%
Profit Per Employee	$-2.3M
ROA	-56.92
Roa5y	-36.16
ROCE	-107.3
ROE	-109.8
Roe5y	-68.12
ROIC	-69.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	8.36%
Cagr3y	-1.32%
Cagr5y	-18.73%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$208.5M
Cash	$200.4M
Current Assets	$205M
Current Liabilities	$47.8M
Debt	$3.8M
Debt Equity	$0.02
Equity	$158M
Liabilities	$50.5M
Long Term Assets	$3.5M
Long Term Liabilities	$2.7M
Net Cash	$196.6M
Net Cash By Market Cap	$49.24
Net Cash Growth	28.79%
Net Debt Equity	$-1.24
Tangible Book Value	$158M
Tangible Book Value Per Share	$1.51
WACC	8.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.29
Net Working Capital	$-42.1M
Quick ratio	4.21
Working Capital	$157.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-24.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	8.36%
200-day SMA	3.91
3Y total return	-3.89%
50-day SMA	3.57
50-day SMA vs 200-day SMA	50under200
5Y total return	-64.55%
All Time High	25.87
All Time High Change	-85.21%
All Time High Date	2020-12-08
All Time Low	1.53
All Time Low Change	150%
All Time Low Date	2022-08-05
ATR	0.27
Beta	0.84
Beta1y	0.78
Beta2y	1.65
Ch YTD	0.39
High	3.9
High52	6.42
High52 Date	2026-02-25
High52ch	-40.42%
Low	3.6
Low52	2.72
Low52 Date	2026-02-23
Low52ch	40.88%
Ma50ch	7.02%
Premarket Change Percent	0
Premarket Price	$3.63
Price vs 200-day SMA	-2.05%
RSI	52.39
RSI Monthly	47.8
RSI Weekly	49.27
Sharpe ratio	0.54x
Sortino ratio	1.04
Total Return	-24.53%
Tr YTD	0.39
Tr1m	19.53%
Tr1w	-4.61%
Tr3m	-11.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	5
Analyst Price Target Top	$11
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.38
Operating Income	$-172.4M
Price target	$14.4
Price Target Change	$276
Price Target Change Top	$188

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	59,939,923%
Float Percent	57.42%
Shares Insiders	1.16%
Shares Institutions	43.76%
Shares Out	104,382,937
Shares Qo Q	5.96%
Shares Yo Y	24.53%
Short Float	18.86%
Short Ratio	3.69
Short Shares	10.83

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-138.5M
Adjusted OCF	-138,424,000
Average Volume	1,766,426.05x
Bv Per Share	1.51
CAPEX	$-42,000
Ch1m	19.53
Ch1w	-4.61
Ch1y	8.36
Ch3m	-11.87
Ch3y	-3.89
Ch5y	-64.55
Ch6m	7.14
Change	5.37%
Change From Open	4.79
Close	3.63
Days Gap	0.55
Depreciation Amortization	326,000
Dollar Volume	3,951,488.9
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-172.4M
EBITDA	$-172.1M
EPS	$-2.09
F Score	1
FCF	$-131.3M
FCF EV Yield	-64.8x
FCF Per Share	$-1.26
Financing CF	173,201,000
Fiscal Year End	December
Investing CF	114,861,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-19
Ma150	3.95
Ma150ch	-3.12%
Ma20	3.78
Ma20ch	1.3%
Net CF	156,787,000
Next Earnings Date	2026-08-13
Open	3.65
Optionable	Yes
Position In Range	76.27
Post Close	3.83
Postmarket Change Percent	-5.15
Postmarket Price	$3.63
Ppne	2,424,000
Pre Close	3.63
Price Date	2026-07-30
Ptbv Ratio	2.53
Relative Volume	0.58x
Share Based Comp	7,149,000
Tr6m	7.14%
Us State	Pennsylvania
Volume	1,033,069

Larimar Therapeutics, Inc. (LRMR)

Coverage state: Market snapshot only — no published research

Generate the first LRMR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · LRMR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LRMR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LRMR

Frequently asked questions